Personalized Medicine: A New Normal for Therapeutic Success

被引:4
作者
Sarvan, M. S. [1 ]
Nori, Lakshmi Prasanthi [2 ]
机构
[1] Vignan Coll Pharm, Dept Pharm, Vadlamudi, India
[2] Vignans Fdn Sci Technol & Res Deemed Univ, Dept Pharmaceut Sci, Guntur 522213, Andhra Pradesh, India
关键词
Personalized medicine; precision medicine; genomics; biomarkers; epigenetics; DNA METHYLATION BIOMARKERS; DISEASES; PHARMACOGENOMICS; ASSOCIATION; EPIGENETICS; VALIDATION; METABOLISM; EXPRESSION;
D O I
10.36468/pharmaceutical-sciences.790
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this article is to provide a framework for understanding the principles of personalized and precision medicine. Since the advent of the human genome project in 1990, the approach to precision and accurate medicine has been changed. This turns the practice from the "one size fits all" paradigm into one that tailors patient identification, diagnosis and treatment. Personalized medicine has been a disputed vision of the future for two decades. A humanized approach to personalized medicine will offer the possibility of leveraging the physiology of processes and its application of personalized, predictive, participatory, precision and preventive P5 medicine. The predictive variables for the progression of a disease should be investigated within communities to determine preventive measures for at risk people and healthcare can be customized and participative. Accurate diagnosis, surveillance and treatment of diseases includes developments in the identification of biomarkers, the subsequent development of reliable signatures that suit complex disease states, as well as medical approaches that can be continually modified and modulated for dosage and medication selection. This review illustrates significant breakthroughs in the advancement of emerging technology and obstacles of personalized and precise medicine. It will create groundbreaking capabilities in the realization of fully individualized patient care.
引用
收藏
页码:416 / 429
页数:14
相关论文
共 57 条
  • [1] [Anonymous], 2015, J PRECIS MED
  • [2] [Anonymous], 2011, PREC MED BUILD KNOWL
  • [3] [Anonymous], 2015, PERS MED 101 STOR PERS MED 101 STOR
  • [4] Building the foundation for genomics in precision medicine
    Aronson, Samuel J.
    Rehm, Heidi L.
    [J]. NATURE, 2015, 526 (7573) : 336 - 342
  • [5] Aldehyde-Amine Chemistry Enables Modulated Biosealants with Tissue-Specific Adhesion
    Artzi, Natalie
    Shazly, Tarek
    Baker, Aaron B.
    Bon, Adriana
    Edelman, Elazer R.
    [J]. ADVANCED MATERIALS, 2009, 21 (32-33) : 3399 - +
  • [6] Predictive, preventive, personalized and participatory medicine: back to the future
    Auffray, Charles
    Charron, Dominique
    Hood, Leroy
    [J]. GENOME MEDICINE, 2010, 2
  • [7] Pharmocoepigenetics: a new approach to predicting individual drug responses and targeting new drugs
    Baer-Dubowska, Wanda
    Majchrzak-Celinska, Aleksandra
    Cichocki, Michal
    [J]. PHARMACOLOGICAL REPORTS, 2011, 63 (02) : 293 - 304
  • [8] MicroRNA therapeutics
    Broderick, J. A.
    Zamore, P. D.
    [J]. GENE THERAPY, 2011, 18 (12) : 1104 - 1110
  • [9] A New Initiative on Precision Medicine
    Collins, Francis S.
    Varmus, Harold
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (09) : 793 - 795
  • [10] Collins FS., 2005, BOSTON GLOBE